retatrutide fat loss clinical trial results Before and After: Doctor Reveals Real a 9-week trip on retatrutide

Months 6 to 12 and beyond: maximum results and maintenance The STEP trials showed that semaglutide 2.4 mg produces an average of approximately 15% body weight loss by week 68, roughly 16 months

Restarting at your full maintenance dose risks severe nausea and gastrointestinal distress

Sandoz (Novartis's generic division) filed a biosimilar application for injectable semaglutide with the European Medicines Agency in February 2026

Triple-action medications go one step further by targeting GIP, GLP-1, and glucagon receptors

This means the appetite suppression does not continue to increase proportionally with dose beyond a certain point

But the FDA has restricted the mass compounding of GLP-1s for safety and regulatory concerns